Pursuing the Triple Aim in Hotspotters: Identification and Integrated Care
Complex Patient, Multimorbidity, Psychosocial Problem
About this trial
This is an interventional other trial for Complex Patient focused on measuring high care utilizer, complex patient, problems on multiple life domains, frequent flyer, hotspotter, high needs patient, integrated care, proactive care, personalised care, personalised care plan, positive health tool, multimorbidity, psychosocial problem
Eligibility Criteria
Inclusion Criteria: The patients are ≥ 18yrs The patients are registered within one of the participating GP practices. Patients with at least two acute care encounters in the past 12 months. Acute care encounter is defined as an encounter with out-of-hours GP service, emergency care or acute mental health care.Patients have problems registered in the GP Information system on at least two out of three of the following domains: somatic, mental or social. Somatic problems is having at least one ICPC code on the problem list. Mental problems is having at least one ICPC code from the "P"-chapter on either the problem list, as a reason for encounter, and/or having medication prescribed related to mental health problems. Social problems is having at least one ICPC code from the "Z"-chapter or as reason for encounter, and/or having medication prescribed related to social problems. Exclusion Criteria: The patient is terminal. The patient is living in a residential home. The patient has dementia or a disability that prevents them from communicating effectively.The patient already has experience with the positive health tool. The patient is not competent to make decisions concerning their health. This wil be assessed by the patient's own general practitioner. Veto of the GP
Sites / Locations
- Leiden University Medical centre, department of Public Healht and Primary care (PHEG), location Health Campus The Hague
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Other
Other
Other
Other
Control period 2 months
Control period 4 months
Control period 6 months
Control period 8 months
2 months control period, followed by 12 months intervention, followed by 8 months observation
4 months control period, followed by 12 months intervention, followed by 6 months observation
6 months control period, followed by 12 months intervention, followed by 4 months observation
8 months control period, followed by 12 months intervention, followed by 2 months observation